University of Virginia School of Medicine scientists have developed a bold new approach to drug development and discovery ...

The U.S. Air Force’s A-10C Thunderbolt II has tested a probe-and-drogue refueling adapter in flight, expanding the aircraft’s ...

Explore the recent advances in fuzzing, including the challenges and opportunities it presents for high-integrity software ...

David J. Silvester, a mathematics professor at the University of Manchester, has developed a novel machine-learning method to ...

AI lets you code at warp speed, but without Agile "safety nets" like pair programming and automated tests, you're just ...

DeepCyte, a techbio company building AI toxicology tools for drug development, launched today with $1.5 million in seed funding. The company is introducing two solutions to help biopharma teams detect ...

The number and variety of test interfaces, coupled with increased packaging complexity, are adding a slew of new challenges.

Primary immunodeficiencies (PIDs) represent a diverse group of disorders stemming from genetic mutations that compromise ...

An individual could potentially use an AI model or a combination of models to engineer a dangerous pathogen, launch autonomous cyberattacks on power grids or hospital networks, or create and ...

Cloud-based virtualization, real-time data synchronization, and scalable AI/ML deployment can modernize the testing landscape ...

Endotoxin-free proteins provide a more reliable choice for preclinical research, precise cellular experiments, and ...

Pharmaceutical regulatory consulting for drug developers and CROs: IND CMC, method validation, NDA strategy, and FDA ...